1. Highly Priced Gene Therapies: A Wake-Up Call for Early Price Regulation

   • Feng Xie

   Commentary 08 May 2018 Pages: 883 - 888

   

2. Sensitivity Analysis for Not-at-Random Missing Data in Trial-Based Cost-Effectiveness Analysis: A Tutorial

   • Baptiste Leurent
   • Manuel Gomes
   • James R. Carpenter

   Practical Application Open access 20 April 2018 Pages: 889 - 901

   

3. Ponatinib for Treating Chronic Myeloid Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

   • Abdullah Pandor
   • Matt Stevenson
   • Ruth Wong

   Review Article 26 February 2018 Pages: 903 - 915

4. Ixekizumab for Treating Moderate-to-Severe Plaque Psoriasis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

   • Bram L. T. Ramaekers
   • Robert F. Wolff
   • Manuela A. Joore

   Review Article Open access 26 February 2018 Pages: 917 - 927

   

5. Cost Effectiveness of Human Papillomavirus Vaccination for Men Who have Sex with Men; Reviewing the Available Evidence

   • Didik Setiawan
   • Abrham Wondimu
   • Maarten J. Postma

   Systematic Review 20 April 2018 Pages: 929 - 939

   

6. Does Non-Adherence Increase Treatment Costs in Schizophrenia?

   • Mark Pennington
   • Paul McCrone

   Systematic Review 26 April 2018 Pages: 941 - 955

   

7. Cost-Effectiveness of Biological Asthma Treatments: A Systematic Review and Recommendations for Future Economic Evaluations

   • R. Brett McQueen
   • Danielle N. Sheehan
   • Jonathan D. Campbell

   Systematic Review 08 May 2018 Pages: 957 - 971

   

8. Comparing the Relative Importance of Attributes of Metastatic Renal Cell Carcinoma Treatments to Patients and Physicians in the United States: A Discrete-Choice Experiment

   • Juan Marcos González
   • Justin Doan
   • Mayer Fishman

   Original Research Article 05 June 2018 Pages: 973 - 986

   

9. Applying GRADE Criteria to Clinical Inputs to Cost-Effectiveness Modeling Studies

   • Alexander Mensch
   • Tanja Beck
   • Dirk Müller

   Original Research Article 28 May 2018 Pages: 987 - 994

   

10. Effects of County Public Hospital Reform on Procurement Costs and Volume of Antibiotics: A Quasi-Natural Experiment in Hubei Province, China

    • Yuqing Tang
    • Chaojie Liu
    • Keyuan Zuo

    Original Research Article Open access 18 April 2018 Pages: 995 - 1004

    

11. Costs of Cancer Care for Elderly Patients with Neuroendocrine Tumors

    • Chan Shen
    • Arvind Dasari
    • Ya-Chen Tina Shih

    Original Research Article 23 April 2018 Pages: 1005 - 1013

12. Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK

    • Paul Emery
    • Marjolijn Van Keep
    • Helena Marzo-Ortega

    Original Research Article Open access 25 May 2018 Pages: 1015 - 1027

    

13. Comment on: “Mapping the Paediatric Quality of Life Inventory (PedsQL™) Generic Core Scales Onto the Child Health Utility Index-9 Dimension (CHU-9D) Score for Economic Evaluation in Children”

    • Emma Frew
    • Tosin Lambe

    Letter to the Editor 20 June 2018 Pages: 1029 - 1029